Page 1649 - Clinical Small Animal Internal Medicine

Index 1587

yersiniosis 953 canine myocardial disease 263–265 etiology/pathophysiology 995
VetBooks.ir nocosomial and multidrug‐ diagnosis 264–265 public health implications 997
see also individual classes/agents;
history and clinical signs 996, 996
cardiogenic shock 414
epidemiology 263–264
resistant infections
treatment and prognosis 997
antioxidants etiology/pathophysiology 263, 263 aspiration pneumonia 558, 559
canine inflammatory liver feline myocardial disease 267, aspiration pneumonitis 292
disease 700–701 269–272 assist/control (A/C) ventilation
chronic kidney disease 1172 history and clinical signs 264 394, 396
gallbladder and extrahepatic biliary prognosis 265 association measures 12–15
ducts 725 signalment 264 asthma see feline bronchial asthma
antiplatelet agents 322–323 treatment 265 astrocytomas 779
antipruritic agents 1400 arterial blood gas (ABG) asymptomatic bacteriuria 1191
antithrombin 315, 316 critical care setting 350 ataxia 732
antithrombotics 188, 191–192, 1105 pulmonary thromboembolism 316 ATE see arterial thromboembolism
antithyroid drugs 78 respiratory monitoring in critical atelectasis 325
antitoxin therapy 807–808 care 376–377, 376 atopic dermatitis 1403–1412
antivenins 462–464, 808 respiratory pattern‐based approach allergen‐specific immunotherapy
antivirals see antimicrobials; individual to dyspnea 293 1411–1412
classes/agents shock 407–408 approach to the dermatologic
anuria 1177–1178 surgical approaches to thoracic patient 1376
anxiety 197 disease 328 diagnosis 1406–1408, 1407
aortic body tumors (ABT) 1271 arterial thromboembolism (ATE) 269, epidemiology 1403–1404
aortic insufficiency 147, 156–157 270–271, 273 etiology/pathophysiology 1403
aortic thromboembolism (ATE) 320 arterioportal fistulae 673 feline bronchial asthma 300
APC see antigen‐presenting cells arthritis history and clinical signs
apheresis 1369–1372 Lyme borreliosis 941–943 1404–1406, 1404–1406
bone marrow transplantation 1371 nonhemotropic Mycoplasma, medical therapy 1408–1411
cell separator machines 1369 Ureaplasma, and L‐form otitis externa 1471–1472
companion animal apheresis bacteria 933 prognosis 1412
1370–1372 see also osteoarthritis signalment 1404
leukopheresis 1370, 1371 arthropod‐borne infections 839–843 treatment 1408–1412
physician‐based applications see also individual agents/diseases ATP see adenosine triphosphate
1369–1370 arthroscopy 1531, 1532, 1542–1545 ATP‐binding cassette (ABC)
plateletpheresis 1369, 1372 articular‐epiphyseal complex proteins 1046
apocrine gland adenoma/ (AEC) 1511–1512 atresia ani 611–612, 611
carcinoma 1354 artifactual hypoglycemia 104–105 atrial enlargement
APP see acute phase proteins ARVC see arrhythmogenic right cardiovascular disease 130,
appetite 584–585, 1167–1168 ventricular cardiomyopathy 134–137
APS see autoimmune polyglandular aryl‐hydrocarbon‐receptor interacting electrocardiography 172, 173, 174
syndromes protein (AIP) 43–44 feline myocardial disease 271, 273
APSS see acquired portosystemic ascending reticular activating system valvular heart disease 246–247
shunts (ARAS) 731, 753 atrial fibrillation (AF) 212–215
ARAS see ascending reticular activating ascites canine myocardial disease
system cirrhosis 705–706, 709–710 255–256
ARB see angiotensin receptor blockers feline inflammatory liver cardiogenic shock 415, 419–420
ARD see antibiotic‐responsive diarrhea disease 688, 693 diagnosis 213, 214
ARDS see acute respiratory distress pathophysiology 643 epidemiology/signalment
syndrome portosystemic shunts and 212–213
arginine 678–679 microvascular etiology/pathophysiology 212
arginine vasopressin (AVP) see dysplasia 715–716 history and clinical signs 213
antidiuretic hormone aspartate aminotransferase (AST) see treatment and prognosis
arrhythmias see electrocardiography; enzyme markers of liver disease 213–215
supraventricular arrhythmias; aspergillosis 995–997 atrial septal defect (ASD) 231–233,
ventricular arrhythmias diagnosis 996 237, 239, 241–243
arrhythmogenic right ventricular epidemiology and atrioventricular (AV) block, cardiogenic
cardiomyopathy (ARVC) signalment 995–996 shock 413–414, 419